Cogent Biosciences
COGT
#3149
Rank
โ‚น450.22 B
Marketcap
โ‚น2,588
Share price
-0.25%
Change (1 day)
-16.31%
Change (1 year)

Earnings for Cogent Biosciences (COGT)

Earnings in 2026 (TTM): -โ‚น34.17 Billion

According to Cogent Biosciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น30.4 Billion a decrease over its 2024 earnings that were of -โ‚น24.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cogent Biosciences from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น34.17 Billion12.4%
2025 -โ‚น30.4 Billion22.64%
2024 -โ‚น24.79 Billion27.67%
2023 -โ‚น19.42 Billion40.78%
2022 -โ‚น13.8 Billion95.68%
2021 -โ‚น7.05 Billion114.09%
2020 -โ‚น3.3 Billion9.67%
2019 -โ‚น3.01 Billion-10.63%
2018 -โ‚น3.36 Billion37.68%
2017 -โ‚น2.44 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น14.85 Billion-57.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.7 Billion-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA